This Slide: #95 of 100 |
Slide #95. Becton, Dickinson and Company — Cato Software Solutions
Acquirer:
Becton, Dickinson and Company (NYSE:BDX)
Acquiree:
Cato Software Solutions
Details:
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired Cato Software Solutions, the manufacturer of cato and chemocato software, a suite of comprehensive medication safety solutions for pharmacy intravenous medication preparation, physician therapy planning and nurse bedside documentation.
Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s operations consist of three business segments: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems; and BD Interventional, which provides vascular, urology, oncology and surgical products.
Becton Dickinson SEC Filing Email Alerts Service
Preferred: BDXB
Open the BDX Page at The Online Investor »
|
Open the BDX Page at The Online Investor (in a new window) »
Free BDX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (3.53 out of 4) 60th percentile
(ranked higher than approx. 60% of all stocks covered)
Analysts' Target Price: BDX Stock Forecast Based on Zacks ABR data; powered by Xignite |